PURPLE BIOTECH is trading at 151.80 as of the 28th of September 2021, a No Change since the beginning of the trading day. The stock's open price was 151.8. Equity ratings for PURPLE BIOTECH are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of October 2020 and ending today, the 28th of September 2021. Click here to learn more.
Check how we calculate scores


Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United States. Purple Biotech Ltd. was founded in 2010 and is headquartered in Rehovot, Israel. PURPLE BIOTECH operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 13 people. more on PURPLE BIOTECH
PURPLE BIOTECH is not yet fully synchronised with the market data
The company reported the revenue of 1000 K. Net Loss for the year was (28 M) with profit before overhead, payroll, taxes, and interest of 1000 K.
PURPLE BIOTECH has accumulated about 57.8 M in cash with (12.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.33.
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of PURPLE BIOTECH's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedOvervalued
PURPLE BIOTECH (PPBT) is traded on Tel Aviv Stock Exchange in Israel and employs 13 people. The company currently falls under 'Small-Cap' category with current market capitalization of 306.09 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PURPLE BIOTECH's market, we take the total number of its shares issued and multiply it by PURPLE BIOTECH's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. PURPLE BIOTECH operates under Healthcare sector and is part of Biotechnology industry. The entity has 175.11 M outstanding shares. PURPLE BIOTECH has accumulated about 57.8 M in cash with (12.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.33.
Check PURPLE BIOTECH Probability Of Bankruptcy

PURPLE Stock Price Odds Analysis

What are PURPLE BIOTECH's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of PURPLE BIOTECH jumping above the current price in 90 days from now is about 51.47%. The PURPLE BIOTECH probability density function shows the probability of PURPLE BIOTECH stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon PURPLE BIOTECH has a beta of -0.6701 indicating as returns on benchmark increase, returns on holding PURPLE BIOTECH are expected to decrease at a much lower rate. During the bear market, however, PURPLE BIOTECH is likely to outperform the market. Additionally, the company has an alpha of 0.2436, implying that it can generate a 0.24 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Odds Down 151.8HorizonTargetOdds Up 151.8 
48.38%90 days
Based on a normal probability distribution, the odds of PURPLE BIOTECH to move above the current price in 90 days from now is about 51.47 (This PURPLE BIOTECH probability density function shows the probability of PURPLE Stock to fall within a particular range of prices over 90 days) .


Investors will always prefer to have the highest possible return on investment while minimizing volatility. PURPLE BIOTECH market risk premium is the additional return an investor will receive from holding PURPLE BIOTECH long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in PURPLE BIOTECH. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although PURPLE BIOTECH's alpha and beta are two of the key measurements used to evaluate PURPLE BIOTECH's performance over the market, the standard measures of volatility play an important role as well.

PURPLE Stock Against Markets

Picking the right benchmark for PURPLE BIOTECH stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in PURPLE BIOTECH stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for PURPLE BIOTECH is critical whether you are bullish or bearish towards PURPLE BIOTECH at a given time.

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with PURPLE BIOTECH stock to make a market-neutral strategy. Peer analysis of PURPLE BIOTECH could also be used in its relative valuation, which is a method of valuing PURPLE BIOTECH by comparing valuation metrics with similar companies.
Please check Your Equity Center. Note that the PURPLE BIOTECH information on this page should be used as a complementary analysis to other PURPLE BIOTECH's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Tools for PURPLE Stock

When running PURPLE BIOTECH price analysis, check to measure PURPLE BIOTECH's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PURPLE BIOTECH is operating at the current time. Most of PURPLE BIOTECH's value examination focuses on studying past and present price action to predict the probability of PURPLE BIOTECH's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move PURPLE BIOTECH's price. Additionally, you may evaluate how the addition of PURPLE BIOTECH to your portfolios can decrease your overall portfolio volatility.
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Bond Directory
Find actively traded corporate debentures issued by US companies
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum